Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 11;2047487320924501.
doi: 10.1177/2047487320924501. Online ahead of print.

Cardiovascular Disease and COVID-19: Les Liaisons Dangereuses

Free PMC article

Cardiovascular Disease and COVID-19: Les Liaisons Dangereuses

Andrea Barison et al. Eur J Prev Cardiol. .
Free PMC article


Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations.

Keywords: COVID-19; Coronavirus; SARS-CoV-2; cardiovascular; comorbidities; risk factors.


Figure 1.
Figure 1.
Interplay between cardiovascular (CV) disease or risk factors and coronavirus disease 19 (COVID-19). Arrows indicate association or cause–effect relationship. ACS: acute coronary syndrome; HF: heart failure.

Similar articles

See all similar articles


    1. John Hopkins University & Medicine. Covid-19 Map, (2020).
    1. Statista. Covid-19/Coronavirus, (2020).
    1. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation, Epub ahead of print 3 April 2020. DOI: 10.1161/CIRCULATIONAHA.120.047164.
    1. Hu H, Ma F, Wei X, et al. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J, Epub ahead of print 16 March 2020. DOI: 10.1093/eurheartj/ehaa190. - PMC - PubMed
    1. Akhmerov A, Marban E. COVID-19 and the heart. Circ Res, Epub ahead of print 7 April 2020. DOI: 10.1161/CIRCRESAHA.120.317055.

LinkOut - more resources